We are extremely pleased for having been selected to received funding from the @LeverhulmeTrust for a visiting professorship. Ove Granstrand, one of Europe’s leading interdisciplinary expert in IP research will be visiting the IIPM research group at CTM and the University of Cambridge Department of Engineering in the coming academic year.
We had a great session today thanks to our participants and particularly the three speakers, including Jorge Contreras (University of Utah) who spoke about patent pledges, Sonia Cooper (Microsoft) who introduced the Azure programme and its IP features and Iain Thomas (Cambridge Enterprise) who gave his view on the university’s role in the innovation process and why patenting is (sometimes) necessary to attract investments so that innovations make it to the patients.
Impressions from today’s session plus some pictures of previous sessions are available here: https://www.flickr.com/photos/synbiosri/41580408664/in/album-72157669307146968/
On Monday and Tuesday this week we welcomed a group of mostly German professors in Technology and Innovation Management from Darmstadt, Bonn, Hannover, Berlin, Münster and Kiel for the annual Hauschildt Innovation Symposium (also known as the Hauschildt Schüler Treffen).
I was very pleased to host this year’s symposium with Hermann Hauser as keynote speaker, who shared his rich experience with the group on the ICT, computer and software industry and the role of the Cambridge cluster. His talk was followed by a trip to the Bradfield Centre at the Cambridge Science Park, kindly hosted by Jeanette Walker, the Science Park’s director. The first day came to a close after a dinner with long lasting discussions at Christs‘ College. During the second day we visited the University’s Maxwell Centre, where Aga and Alexandra provided two excellent talks on the idea of the Maxwell Centre and its mission as well as the Impulse programme for Tech Innovators.
Dr Thomas operates within the Technology Transfer team; the work of which includes invention disclosure management, patent strategy, proof of concept funding, research reagents transfer, intellectual property licensing and bespoke marketing. Iain works predominantly with technologies in the fields of biology and chemistry with products such as alemtuzumab (Sanofi), breast cancer markers (Brevagen) and mouse touch screen chambers (Campden Instruments).
Short article on the above topic in the recenlty published newsletter of the Department of Engineering, University of Cambridge available for reading here.